0000950170-24-083951.txt : 20240716
0000950170-24-083951.hdr.sgml : 20240716
20240716164036
ACCESSION NUMBER: 0000950170-24-083951
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240716
DATE AS OF CHANGE: 20240716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eisner Mark
CENTRAL INDEX KEY: 0001834161
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 241120092
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
ownership.xml
4
X0508
4
2024-07-15
0001706431
Vir Biotechnology, Inc.
VIR
0001834161
Eisner Mark
C/O VIR BIOTECHNOLOGY, INC.
1800 OWENS STREET, SUITE 900
SAN FRANCISCO
CA
94158
false
true
false
false
EVP and Chief Medical Officer
false
Common Stock
2024-07-15
4
A
false
75000
0
A
75000
D
Stock Option (Right to Buy)
9.37
2024-07-15
4
A
false
150000
0
A
2034-07-14
Common Stock
150000
150000
D
Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
25% of the shares subject to the stock option vest and become exercisable on July 15, 2025, and the remainder vest in 36 equal monthly installments thereafter.
/s/ Vanina de Verneuil, Attorney-In-Fact
2024-07-16